Treatment of Chronic Migraine Headaches.

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Chronic Migraine Without Aura, Intractable, Migraine With Typical Aura, Migraine Disorders

In brief

The purpose of the study is assessment of the safety and efficacy of the De-Novo therapy in the treatment of craniofacial neuralgia and migraine headaches.This is an open-label study of simultaneous administration of combination of dexamethasone, lidocaine, and thiamine into the trigeminal nerve branches as well as greater and lesser occipital nerve bilaterally in one session. Patients who meet the exclusion and inclusion criteria are eligible for trial if they have experienced chronic migraine and craniofacial pain not responding to other prior therapies.

Key facts

Study ID
NCT03220113
Run by
Corona Doctors Medical Clinics, Inc.
People needed
100
Starts
2017-07-01
Expected to finish
2019-07-01
Last updated by the study team
2018-04-04

Who can join

Age: 10 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.